A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays

Viral Immunology

Volumn 23, Issue 4, 2010, Pages 353-357

  Greenwood, Nicholas P ^a   Ovsyannikova, Inna G ^a   Vierkant, Robert A ^a   O'Byrne, Megan M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; DRUG EFFECT; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RUBELLA; RUBELLA VIRUS;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CHILD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MONITORING, IMMUNOLOGIC; REAGENT KITS, DIAGNOSTIC; RUBELLA; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY; VACCINATION; YOUNG ADULT;

RUBELLA; RUBELLA VIRUS;

EID: 77955874010     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0026     Document Type: Article

References (17)

1. Aboudy Y, Barnea B, Yosef L, Frank T, and Mendelson E: Clinical rubella reinfection during pregnancy in a previously vaccinated woman. J Infect 2000;41:187-189.
2. Bland JM, and Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8476:307-310.
3. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, 10th ed., 2nd printing. Public Health Foundation, Washington, 2008.
4. Chantler JK, Lund KD, Miki NPH, Berkowitz CA, and Tai G: Characterization of rubella virus strain differences associated with attenuation. Intervirology 1993;36:225-236.
5. Date AA, Kyaw MH, Rue AM, et al.: Long-term persistence of mumps antibody after receipt of 2 measles-mumpsrubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008;197:1662-1668.
6. Davidkin I, Peltola H, Leinikki P, and Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 2000;18:3106-3112.
7. Dimech W, Bettoli A, Eckert D, et al.: Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter. J Clin Microbiol 1992;30:633-641.
8. Dimech W, Panagiotopoulos L, Francis B, et al.: Evaluation of eight anti-rubella virus immunoglobulin G immunoassays that report results in international units per milliliter. J Clin Microbiol 2008;46:1955-1960.
9. Dorsett PH, Miller DC, Green KY, and Byrd FI: Structure and function of the rubella virus proteins. Rev Infect Dis 1985;7(Suppl 1):S150-S156.
10. Hardelid P, Williams D, Dezateux C, CubittWD,Peckham CS, Tookey PA et al.: Agreement of rubella IgG antibody measured in serum and dried blood spots using two commercial enzyme-linked immunosorbent assays. J Med Virol 2008; 80:360-364.
11. Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-268.
12. Meissner HC, Reef SE, and Cochi S: Elimination of rubella from the United States: a milestone on the road to global elimination. Pediatrics 2006;117:933-935.
13. Nickerson CAE: A note on "A concordance correlation coefficient to evaluate reproducibility." Biometrics 1997;53:1503-1507.
14. Ovsyannikova IG, Jacobson RM, Ryan JE, Dhiman N, Vierkant RA, and Poland GA: Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol 2007;14:115-122.
15. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, and Poland GA: The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004;65:1506-1515.
16. Plotkin SA: The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis 2006;43(Suppl 3): S164-S168.
17. Skendzel LP: Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996;106:170-174.